Related Experiment Videos
Malignant external otitis. Comparison of monotherapy vs combination therapy
Archives of Otolaryngology--Head & Neck Surgery
|September 1, 1987
Summary
Antipseudomonal cephalosporin monotherapy is effective for treating malignant external otitis (MEO) in diabetic patients, showing similar outcomes to conventional treatments for moderate infections.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Diabetology
Background:
- Malignant external otitis (MEO) is a severe infection primarily affecting diabetic patients.
- Pseudomonas aeruginosa is the common pathogen in MEO.
- Treatment options for MEO have varied, with a need to evaluate monotherapy efficacy.
Purpose of the Study:
- To compare the efficacy of antipseudomonal cephalosporin monotherapy versus conventional therapy for MEO.
- To analyze patient characteristics and outcomes in MEO treatment.
Main Methods:
- Retrospective analysis of 20 adult-onset diabetes mellitus patients with MEO.
- Comparison of two treatment groups: cephalosporin monotherapy (Group A) and conventional therapy (Group B).
- Inclusion of patient demographics, comorbidities, and clinical outcomes.
Main Results:
- Both monotherapy and conventional therapy showed similar cure rates (64% vs. 70%).
- Group B patients had higher rates of insulin dependence, vascular disease, cranial nerve palsies, and surgical procedures.
- Less extensive infections correlated with more favorable outcomes in both groups.
Conclusions:
- Antipseudomonal cephalosporin monotherapy is a viable treatment option for MEO, comparable to conventional therapy.
- MEO treatment outcomes are influenced by infection severity.
- Further research into optimal MEO management in diabetic patients is warranted.